Sangoma Introduces Sangoma GenAI Platform, Transforming Business Communications with AI-Powered Innovations
Sangoma Technologies (TSX: STC; Nasdaq: SANG) has unveiled its proprietary AI platform, Sangoma GenAI, introducing several AI-powered innovations in business communications. The platform includes an Enhanced Conversational IVR for streamlining customer interactions, a Patient Relationship Management System developed with Sphinx Medical's CallMyDoc® for healthcare automation, and Sangoma Scribe for voice record transcription and analysis.
The company has also enhanced its Sangoma CX® contact center solution with GoogleFlow-powered chatbots and AI Assist features to improve agent productivity. These innovations aim to optimize operations, customer engagement, and team collaboration while providing affordable enterprise-grade solutions. Sangoma continues its investment in open source projects Asterisk and FreePBX, with plans to showcase AI integration at the upcoming 20th annual AstriCon conference in Fort Lauderdale.
Sangoma Technologies (TSX: STC; Nasdaq: SANG) ha presentato la sua piattaforma AI proprietaria, Sangoma GenAI, introducendo diverse innovazioni alimentate da AI nelle comunicazioni aziendali. La piattaforma include un IVR Conversazionale Avanzato per semplificare le interazioni con i clienti, un Sistema di Gestione delle Relazioni con i Pazienti sviluppato con il CallMyDoc® di Sphinx Medical per l'automazione sanitaria, e Sangoma Scribe per la trascrizione e analisi delle registrazioni vocali.
L'azienda ha inoltre migliorato la sua soluzione di contact center Sangoma CX® con chatbot potenziati da GoogleFlow e funzionalità AI Assist per aumentare la produttività degli agenti. Queste innovazioni mirano a ottimizzare le operazioni, il coinvolgimento dei clienti e la collaborazione tra i team, offrendo soluzioni aziendali a prezzi accessibili. Sangoma continua a investire in progetti open source come Asterisk e FreePBX, con piani per mostrare l'integrazione AI alla prossima 20a conferenza annuale AstriCon a Fort Lauderdale.
Sangoma Technologies (TSX: STC; Nasdaq: SANG) ha presentado su plataforma de IA propietaria, Sangoma GenAI, introduciendo diversas innovaciones impulsadas por IA en las comunicaciones empresariales. La plataforma incluye un IVR Conversacional Mejorado para optimizar las interacciones con los clientes, un Sistema de Gestión de Relaciones con Pacientes desarrollado con CallMyDoc® de Sphinx Medical para la automatización en el sector salud, y Sangoma Scribe para la transcripción y análisis de grabaciones de voz.
La compañía también ha mejorado su solución de centro de contacto Sangoma CX® con chatbots potenciados por GoogleFlow y características de AI Assist para mejorar la productividad de los agentes. Estas innovaciones tienen como objetivo optimizar las operaciones, el compromiso del cliente y la colaboración del equipo, al tiempo que proporcionan soluciones empresariales asequibles. Sangoma continúa su inversión en proyectos de código abierto como Asterisk y FreePBX, con planes para mostrar la integración de IA en la próxima 20ª conferencia anual AstriCon en Fort Lauderdale.
상고마 기술 (TSX: STC; Nasdaq: SANG)이 독자적인 AI 플랫폼인 상고마 GenAI를 공개하며 비즈니스 커뮤니케이션에서 여러 AI 기반 혁신을 선보였습니다. 이 플랫폼은 고객 상호작용을 간소화하기 위한 향상된 대화형 IVR, Sphinx Medical의 CallMyDoc®와 함께 개발된 헬스케어 자동화를 위한 환자 관계 관리 시스템, 음성 기록의 필사 및 분석을 위한 상고마 스크라이브를 포함하고 있습니다.
회사는 또한 상고마 CX® 컨택트 센터 솔루션을 GoogleFlow 기반 챗봇 및 AI 지원 기능으로 강화하여 에이전트의 생산성을 향상시켰습니다. 이러한 혁신은 운영 최적화, 고객 참여, 팀 협업을 목표로 하며, 저렴한 기업급 솔루션을 제공합니다. 상고마는 Asterisk 및 FreePBX와 같은 오픈 소스 프로젝트에 대한 투자를 지속하고 있으며, 가까운 20회 연례 AstriCon 컨퍼런스에서 AI 통합을 선보일 계획입니다.
Sangoma Technologies (TSX: STC; Nasdaq: SANG) a dévoilé sa plateforme IA propriétaire, Sangoma GenAI, en introduisant plusieurs innovations alimentées par l'IA dans les communications professionnelles. La plateforme comprend un IVR Conversationnel Amélioré pour rationaliser les interactions avec les clients, un Système de Gestion des Relations avec les Patients développé avec CallMyDoc® de Sphinx Medical pour l'automatisation des soins de santé, et Sangoma Scribe pour la transcription et l'analyse des enregistrements vocaux.
L'entreprise a également amélioré sa solution de centre de contact Sangoma CX® avec des chatbots alimentés par GoogleFlow et des fonctionnalités d'AI Assist pour améliorer la productivité des agents. Ces innovations visent à optimiser les opérations, l'engagement des clients et la collaboration des équipes tout en fournissant des solutions d'entreprise abordables. Sangoma continue d'investir dans des projets open source tels qu'Asterisk et FreePBX, avec des plans pour présenter l'intégration de l'IA lors de la prochaine 20e conférence annuelle AstriCon à Fort Lauderdale.
Sangoma Technologies (TSX: STC; Nasdaq: SANG) hat seine proprietäre KI-Plattform Sangoma GenAI vorgestellt und mehrere KI-gestützte Innovationen in der Unternehmenskommunikation eingeführt. Die Plattform umfasst ein Verbessertes Konversations-IVR zur Optimierung von Kundeninteraktionen, ein Patientenbeziehungs-Management-System, das mit Sphinx Medicals CallMyDoc® für die Automatisierung im Gesundheitswesen entwickelt wurde, und Sangoma Scribe für die Transkription und Analyse von Sprachaufzeichnungen.
Das Unternehmen hat auch seine Sangoma CX® Contact Center-Lösung mit GoogleFlow-gesteuerten Chatbots und AI Assist-Funktionen verbessert, um die Produktivität der Mitarbeiter zu steigern. Diese Innovationen zielen darauf ab, den Betrieb, das Kundenengagement und die Teamzusammenarbeit zu optimieren und gleichzeitig kostengünstige Unternehmenslösungen anzubieten. Sangoma investiert weiterhin in Open-Source-Projekte wie Asterisk und FreePBX und plant, die KI-Integration auf der bevorstehenden 20. jährlichen AstriCon-Konferenz in Fort Lauderdale zu präsentieren.
- Launch of comprehensive AI platform (Sangoma GenAI) expanding product portfolio
- Strategic partnership with Sphinx Medical for healthcare sector expansion
- Integration of GoogleFlow technology enhancing contact center capabilities
- None.
Insights
The launch of Sangoma GenAI marks a strategic pivot that could significantly impact Sangoma's market position in the $50 billion business communications sector. The platform's architecture demonstrates sophisticated integration of multiple AI technologies, addressing critical pain points in enterprise communications:
The Enhanced Conversational IVR and Sangoma Scribe represent high-margin opportunities in the rapidly growing speech analytics market, projected to reach $4.5 billion by 2027. The successful implementation at a Michelin-starred restaurant validates the platform's enterprise-grade capabilities and suggests strong potential for vertical-specific solutions.
Particularly noteworthy is the Patient Relationship Management integration with Electronic Health Records, positioning Sangoma in the lucrative healthcare IT sector. This strategic move targets the $15.8 billion healthcare CRM market, where AI-driven automation can significantly reduce operational costs.
The continued investment in open-source projects Asterisk and FreePBX represents a savvy strategy to:
- Maintain developer mindshare and community support
- Reduce development costs while accelerating innovation
- Create a pipeline for enterprise product adoption
The platform's integration with GoogleFlow for chatbots indicates strong partnerships with major tech players, potentially reducing development costs and accelerating market deployment. However, the success will largely depend on:
- Integration capabilities with existing enterprise systems
- ROI demonstration through measurable efficiency gains
- Competitive pricing strategy in a market with established players
Sangoma's COO, Jeremy Wubs, emphasizes Sangoma's mission to “simplify communication and solve industry challenges with intelligent, scalable platforms powered by Sangoma GenAI, delivering affordable enterprise-grade solutions.”
With an agentic AI approach, these new functionalities optimize operations, customer engagement, and team collaboration:
- Enhanced Conversational IVR: An Interactive Voice Response for streamlining customer interactions and gathering detailed customer feedback ratings. A Michelin-starred restaurant improved its reservation process by integrating this technology.
- Patient Relationship Management (PRM) System: In partnership with Sphinx Medical’s CallMyDoc®, this AI-driven system integrates with Electronic Health Records (EHRs), automating appointments, prescriptions, and telehealth communications, while reducing follow-ups.
- Sangoma Scribe: Provides transcription, summarization, and sentiment analysis for voice records, helping companies track calls, measure customer satisfaction, and refine strategies. Sangoma Meet also offers live transcription and meeting summaries.
Sangoma CX® also integrates AI to enhance contact center productivity with:
- Chatbots and Virtual Assistants powered by GoogleFlow to automate routine tasks and initial interactions.
- AI Assist to improve agent responses with grammar fixes, tone adjustments, and message simplification, reducing response times.
Dedicated to the development of next-gen AI solutions, Sangoma also continues to invest in the leading global open source projects, Asterisk and FreePBX, introducing innovations like the previously mentioned Sangoma Scribe. “Scribe has been enthusiastically received, helping companies make smarter decisions from conversations, and quickly gaining adoption among users,” said Michael White, Sangoma’s VP of Open Source.
Sangoma will host the 20th annual AstriCon conference in February at
About Sangoma Technologies Corporation
Sangoma (TSX: STC; Nasdaq: SANG) is a leading business communications platform provider with solutions that include its award-winning UCaaS, CCaaS, CPaaS, and Trunking technologies. The enterprise-grade communications suite is developed in-house; available for cloud, hybrid, or on-premises deployments. Additionally, Sangoma’s integrated approach provides managed services for connectivity, network, and security.
A trusted communications partner with over 40 years on the market, Sangoma has over 2.7 million UC seats across a diversified base of over 100,000 customers. Sangoma has been recognized for ten years running in the Gartner UCaaS Magic Quadrant.
As the primary developer and sponsor of the open source Asterisk and FreePBX projects, Sangoma is determined to drive innovation in communication technology.
For more information, visit www.sangoma.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250128414742/en/
Maria Scheifler
VP of Global Marketing
pr@sangoma.com
941-960-8458
Source: Sangoma Technologies Corporation
FAQ
What new AI features has Sangoma (SANG) introduced in its GenAI platform?
How is Sangoma (SANG) implementing AI in healthcare communications?
What are the key features of Sangoma Scribe in the SANG GenAI platform?
How is Sangoma (SANG) enhancing its contact center solution with AI?
